Pérez GJH, Solís CJH, Alfaro GJG

Language: Spanish
References: 14
Page: 498-502
PDF size: 74.95 Kb.

ABSTRACT

We report the case of a female patient who suffered from fever syndrome and arthralgias, presented antinuclear antibodies titers and had a history of penicillin allergy. We suspected clinical diagnosis of drug-induced lupus. Drug withdrawal was associated with the remission of clinical manifestations. This study was performed to determine the correlation between psychiatric manifestations and drug-induced lupus. The patient received corticosteroids, (methylprednisolone bolus), as well as cyclophosphamide; remission with treatment was observed.

REFERENCES

1. Ellenhorn MJ, Schonwald S, Ordog G. Ellenhorn’s medical toxicology: diagnosis and treatment of human poisoning. 2nd ed. Baltimore: Williams & Wilkins, 1997;p:797.

2. Sánchez L, Galarza D. Manifestaciones neuropsiquiátricas en el lupus eritematoso sistémico. En: Ramiro M. Medicina Interna de México 1996;12:218-27.

3. Jennekens FG, Kater L. The central nervous system in systemic lupus erythematosus. Part 1. Clinical syndromes: a literature investigation. Rheumatology 2002;41:605-18.

4. Conti F, Alessandri C, Bompane D, et al. Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies. Arthritis Res Ther 2004;6(4):R366-72.

5. Waterloo K, Omdal R, Husby G, Mellgren SI. Neuropsychological function in systemic lupus erythematosus: a five-year longitudinal study. Rheumatology (Oxford) 2002;41(4):411-5.

6. Caggiani M, Gazzara G. Lupus eritematoso sistémico en niños y adolescentes. Arch Pediatr Urug 2003;74(4):237-44.

7. Polo PC, Rodríguez VJ, Buchaca FE. Lupus eritematoso sistémico. Embarazo y corea. Rev Cubana Med 1995;34 (1):123-8.

8. Rodríguez A, Zea A. Etiopatogenia y manifestaciones clínicas del lupus eritematoso sistémico. En: John H, Klippel, MD. Principios de enfermedades reumáticas. México. 285-306.

9. Montes J, Valencia F. Alteraciones cognoscitivas en pacientes con lupus eritematoso generalizado. Rev Mex Neuroci 2004;5(2):141-5.

10. Ramírez G, Gamarra G. Guías de práctica clínica basadas en la evidencia. Lupus eritematoso sistémico. PROYECTO ISS - Asociación Colombiana de Facultades de Medicina (ASCOFAME):1-50.

11. Zonana A, Rodríguez L. Factores de riesgo relacionados con lupus eritematoso sistémico en población mexicana. Salud Publica Mex 2002;44:213-8.

12. Jonson A, Nived O. Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortality. Rheumatology 2002;41:1308-12.

13. Stoll L, Gavlchin J. Systemic lupus erythematosus messages from experimental models. Rheumatology 2000;39:18-27.

14. Sabbadini M, Buzzolo E. Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations. Lupus 1999;8(1):9-11.